Different types of resting CD8 immune cells that help fight infections and cancer
Naive CD8 T cell functional heterogeneity
The team is finding which resting CD8 immune cells best become strong infection- and cancer-fighting cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11306091 on NIH RePORTER |
What this research studies
You would hear that researchers are comparing subgroups of 'naive' CD8 T cells—the immune cells that haven't yet met germs—by examining their behavior and gene activity and seeing which ones most readily turn into powerful killer cells. The work combines lab experiments, animal models, and studies of human blood or tissue samples to trace how these differences arise and persist. By pinpointing what makes some naive cells higher quality, the team aims to learn ways to produce more of those cells. This could guide strategies to boost vaccine responses or design cell-based therapies in the future.
Who could benefit from this research
Good fit: Adults and newborns (with parental consent) who can give blood or tissue samples, and patients with infections or cancer when clinical samples are included, would be the most likely candidates to participate.
Not a fit: People needing immediate clinical treatment or those unable or unwilling to provide samples or travel to the study site are unlikely to receive direct benefit from this primarily lab-focused project.
Why it matters
Potential benefit: If successful, this work could enable vaccines or therapies that produce stronger, longer-lasting T cell protection against infections and some cancers.
How similar studies have performed: Other research has identified functional subsets in effector and memory CD8 cells and early data suggest some naive CD8 cells are superior, but translating these basic findings into human treatments is still at an early stage.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Araki, Koichi — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Araki, Koichi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.